All news

Rethink Medical reaches the minimum target of its 2026 investment round

BD Kapital campaign panel showing the Rethink Medical II investment round reaching its target

Rethink Medical reached the minimum target of its 2026 investment round ahead of the initially planned closing date.

The financing supports the company's next stage of development as it progresses its manufacturing, regulatory, commercial and internationalisation activities around T-Control®.

We thank the investors and supporters who continue to accompany Rethink Medical through this next phase.

More news

Alba Jiménez Martel, Industrial Engineer, at her desk in the Rethink Medical office

Rethink Medical strengthens its R&D team to advance T-Control® development

Rethink Medical has welcomed Industrial Engineer Alba Jiménez Martel to strengthen its innovation team and contribute to the development of a new catheterisation solution aimed at addressing complex urinary catheterisation situations. The project includes the design and development of a new catheter tip and is supported through the IPI programme.

IPI Project · ESF+